Fairtility to give presentations at the ESHRE 2022 meeting in Milan

Fairtility, the Israeli AI innovator powering in vitro fertilisation (IVF), will present five abstracts and seven posters at the Annual European Society of Human Reproduction and Embryology (ESHRE) Meeting in Milan.

The company’s research presents qualitative and quantitative data showcased in the 12 total presentations at ESHRE.

Fairtility’s proprietary AI-powered embryo quality assessment assistant, CHLOE EQ™ (Cultivating Human Life through Optimal Embryos), provides embryologists with previously unachievable data supporting embryo selection, creating an opportunity to clearly explain analysis results based on quantifiable biological parameters.

“Embryologists are longing for a solution that will bring standardisation, accuracy, and greater efficiency to their emotional and impactful work,” says Dr. Cristina Hickman, VP of clinical affairs with Fairtility. In the embryology lab, we must carefully maintain and protect the potential of life at its earliest stages. We feel a strong sense of responsibility to patients as they work to fulfil their dream of becoming parents.

“Fairtility is the only solution I know of that provides the level of transparency that embryologists really expect from an AI system,” she adds. “Having this information available on the ‘WHY’ behind our recommendations positions CHLOE to reshape the conversation between IVF professionals and their patients.”

Along with other fertility clinic partners, the Israeli company will give five oral presentations at ESHRE. Registrations for the meeting, taking place in Milan, Italy between July 3-6, 2022, can be found here.

“We are investing heavily in clinical validation for CHLOE EQ™, as we believe we must hold ourselves accountable to the industry’s highest standards of clinical evidence and validation,” says Eran Eshed, CEO and co-founder of Fairtility.

“Just as any medical device must go through rigorous assessment to achieve regulatory clearance, we are continuously testing, analysing and improving CHLOE EQ™’s accuracy and usability. It has the potential to help fertility clinics improve their clinical outcomes, reduce the number of cycles to live birth and improve workflow efficiency. Crucially, it is designed to earn physicians and embryologists’ trust by introducing visibility into the IVF process.”

For more information, visit fairtility.com.